A1BG | Alpha-1-B glycoprotein | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
AADAC | Arylacetamide deacetylase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
AAMP | Angio-associated, migratory cell protein | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AANAT | Aralkylamine N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AATK | Apoptosis-associated tyrosine kinase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ABHD10 | Abhydrolase domain containing 10 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
ABHD14A | Abhydrolase domain containing 14A | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ABHD14A-ACY1 | ABHD14A-ACY1 readthrough (NMD candidate) | Predicted intracellular proteins
| | | | | Not detected |
ABHD15 | Abhydrolase domain containing 15 | Predicted secreted proteins
| | | | | Expressed in all |
ABHD8 | Abhydrolase domain containing 8 | Predicted intracellular proteins
| | | | | Expressed in all |
ABI3BP | ABI family, member 3 (NESH) binding protein | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
AC010879.1 | | Predicted secreted proteins
| | | | | Tissue enhanced |
AC136352.7 | | Predicted secreted proteins
| | | | | Tissue enhanced |
ACACB | Acetyl-CoA carboxylase beta | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACAN | Aggrecan | Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000464149} | Predicted secreted proteins
| | | | | Tissue enriched |
ACP1 | Acid phosphatase 1, soluble | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACP5 | Acid phosphatase 5, tartrate resistant | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ACP6 | Acid phosphatase 6, lysophosphatidic | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ACRBP | Acrosin binding protein | Predicted secreted proteins
| | | | | Tissue enriched |
ACRV1 | Acrosomal vesicle protein 1 | Predicted secreted proteins
| | | | | Tissue enriched |
ACSF2 | Acyl-CoA synthetase family member 2 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACSF3 | Acyl-CoA synthetase family member 3 | Disease related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACTN1 | Actinin, alpha 1 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACVR1 | Activin A receptor, type I | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACVR1C | Activin A receptor, type IC | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACVRL1 | Activin A receptor type II-like 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ACYP1 | Acylphosphatase 1, erythrocyte (common) type | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ACYP2 | Acylphosphatase 2, muscle type | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM10 | ADAM metallopeptidase domain 10 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM15 | ADAM metallopeptidase domain 15 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM22 | ADAM metallopeptidase domain 22 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM29 | ADAM metallopeptidase domain 29 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM32 | ADAM metallopeptidase domain 32 | Enzymes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM33 | ADAM metallopeptidase domain 33 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ADAM7 | ADAM metallopeptidase domain 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM9 | ADAM metallopeptidase domain 9 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |